Literature DB >> 24418061

Biological heterogeneity in ADNI amnestic mild cognitive impairment.

Jasmine Nettiksimmons1, Charles DeCarli2, Susan Landau3, Laurel Beckett4.   

Abstract

BACKGROUND: Previous work examining normal controls from the Alzheimer's Disease Neuroimaging Initiative (ADNI) identified substantial biological heterogeneity. We hypothesized that ADNI mild cognitive impairment (MCI) subjects would also exhibit heterogeneity with possible clinical implications.
METHODS: ADNI subjects diagnosed with amnestic MCI (n=138) were clustered based on baseline magnetic resonance imaging, cerebrospinal fluid, and serum biomarkers. The clusters were compared with respect to longitudinal atrophy, cognitive trajectory, and time to conversion.
RESULTS: Four clusters emerged with distinct biomarker patterns: The first cluster was biologically similar to normal controls and rarely converted to Alzheimer's disease (AD) during follow-up. The second cluster had characteristics of early Alzheimer's pathology. The third cluster showed the most severe atrophy but barely abnormal tau levels and a substantial proportion converted to clinical AD. The fourth cluster appeared to be pre-AD and nearly all converted to AD.
CONCLUSIONS: Subjects with MCI who were clinically similar showed substantial heterogeneity in biomarkers.
Copyright © 2014 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADNI; Alzheimer's disease; Amnestic MCI; Clustering; Heterogeneity

Mesh:

Substances:

Year:  2014        PMID: 24418061      PMCID: PMC4092059          DOI: 10.1016/j.jalz.2013.09.003

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  30 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment.

Authors:  Charles DeCarli
Journal:  Lancet Neurol       Date:  2003-01       Impact factor: 44.182

3.  Nonlinear registration of longitudinal images and measurement of change in regions of interest.

Authors:  Dominic Holland; Anders M Dale
Journal:  Med Image Anal       Date:  2011-02-23       Impact factor: 8.545

4.  An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.

Authors:  Clifford R Jack; David S Knopman; Stephen D Weigand; Heather J Wiste; Prashanthi Vemuri; Val Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Robert J Ivnik; Rosebud O Roberts; Walter A Rocca; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2012-04-09       Impact factor: 10.422

5.  Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.

Authors:  A Caroli; C Testa; C Geroldi; F Nobili; L R Barnden; U P Guerra; M Bonetti; G B Frisoni
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

6.  Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Authors:  David S Knopman; Clifford R Jack; Heather J Wiste; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

7.  MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.

Authors:  J L Whitwell; M M Shiung; S A Przybelski; S D Weigand; D S Knopman; B F Boeve; R C Petersen; C R Jack
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910

8.  Amyloid imaging in mild cognitive impairment subtypes.

Authors:  David A Wolk; Julie C Price; Judy A Saxton; Beth E Snitz; Jeffrey A James; Oscar L Lopez; Howard J Aizenstein; Ann D Cohen; Lisa A Weissfeld; Chester A Mathis; William E Klunk; Steven T De-Kosky; Steven T DeKoskym
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

Review 9.  Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues.

Authors:  Chris Zarow; Traci E Sitzer; Helena C Chui
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

10.  The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Authors:  Clifford R Jack; Matt A Bernstein; Nick C Fox; Paul Thompson; Gene Alexander; Danielle Harvey; Bret Borowski; Paula J Britson; Jennifer L Whitwell; Chadwick Ward; Anders M Dale; Joel P Felmlee; Jeffrey L Gunter; Derek L G Hill; Ron Killiany; Norbert Schuff; Sabrina Fox-Bosetti; Chen Lin; Colin Studholme; Charles S DeCarli; Gunnar Krueger; Heidi A Ward; Gregory J Metzger; Katherine T Scott; Richard Mallozzi; Daniel Blezek; Joshua Levy; Josef P Debbins; Adam S Fleisher; Marilyn Albert; Robert Green; George Bartzokis; Gary Glover; John Mugler; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

View more
  58 in total

1.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-05-22       Impact factor: 21.566

2.  Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.

Authors:  Ali Ezzati; Andrea R Zammit; Christian Habeck; Charles B Hall; Richard B Lipton
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

3.  Development and validation of risk index for cognitive decline using blood-derived markers.

Authors:  Jasmine Nettiksimmons; Hilsa Ayonayon; Tamara Harris; Caroline Phillips; Caterina Rosano; Suzanne Satterfield; Kristine Yaffe
Journal:  Neurology       Date:  2015-01-21       Impact factor: 9.910

4.  Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment.

Authors:  Emily C Edmonds; Alexandra J Weigand; Kelsey R Thomas; Joel Eppig; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2018-09       Impact factor: 2.892

Review 5.  Clinical workout for the early detection of cognitive decline and dementia.

Authors:  M Tsolaki
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

Review 6.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

7.  Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.

Authors:  Annie M Racine; Rebecca L Koscik; Sara E Berman; Christopher R Nicholas; Lindsay R Clark; Ozioma C Okonkwo; Howard A Rowley; Sanjay Asthana; Barbara B Bendlin; Kaj Blennow; Henrik Zetterberg; Carey E Gleason; Cynthia M Carlsson; Sterling C Johnson
Journal:  Brain       Date:  2016-06-20       Impact factor: 13.501

8.  Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.

Authors:  Aoyan Dong; Jon B Toledo; Nicolas Honnorat; Jimit Doshi; Erdem Varol; Aristeidis Sotiras; David Wolk; John Q Trojanowski; Christos Davatzikos
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

Review 9.  A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.

Authors:  AmanPreet Badhwar; G Peggy McFall; Shraddha Sapkota; Sandra E Black; Howard Chertkow; Simon Duchesne; Mario Masellis; Liang Li; Roger A Dixon; Pierre Bellec
Journal:  Brain       Date:  2020-05-01       Impact factor: 13.501

10.  Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment.

Authors:  Eun Hyun Seo; I L Han Choo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.